Detalles de la búsqueda
1.
The correlation between systemic inflammatory markers and efficiency for advanced gastric cancer patients treated with ICIs combined with chemotherapy.
Immunology
; 172(1): 77-90, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38269606
2.
Long-term survival after neoadjuvant therapy for triple-negative breast cancer under different treatment regimens: a systematic review and network meta-analysis.
BMC Cancer
; 24(1): 440, 2024 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38594636
3.
Cytochrome b561 regulates iron metabolism by activating the Akt/mTOR pathway to promote Breast Cancer Cells proliferation.
Exp Cell Res
; 431(1): 113760, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37634562
4.
Screening Single Nucleotide Polymorphisms Predicting the Efficacy of Electroacupuncture for Fatigue Treatment in Patients with Breast Cancer Following Adjuvant Chemotherapy.
Biochem Genet
; 62(2): 1291-1303, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37596508
5.
Palbociclib plus endocrine therapy in hormone receptor-positive and HER2 negative metastatic breast cancer: a multicenter real-world study in the northwest of China.
BMC Cancer
; 23(1): 103, 2023 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36717797
6.
Therapeutic effect and metabolic fingerprinting of triple-negative breast cancer cells following exposure to a novel pH-responsive, gambogic acid-loaded micelle.
Nanotechnology
; 35(11)2023 Dec 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38081078
7.
Meta-analysis of quality of life in patients with cancer treated with antibody-drug conjugates in randomized controlled trials.
Future Oncol
; 19(32): 2201-2212, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37882431
8.
Updated efficacy of adjuvant epirubicin plus cyclophosphamide followed by taxanes versus carboplatin plus taxanes in early triple-negative breast cancer in phase 2 trial: 8.1-year median follow-up.
Breast Cancer Res Treat
; 191(1): 97-105, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34648118
9.
The role of capecitabine-based neoadjuvant and adjuvant chemotherapy in early-stage triple-negative breast cancer: a systematic review and meta-analysis.
BMC Cancer
; 21(1): 78, 2021 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33468087
10.
Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triple-negative breast cancer: a systematic review and meta-analysis.
BMC Cancer
; 21(1): 1261, 2021 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34814874
11.
A comparison between triplet and doublet chemotherapy in improving the survival of patients with advanced gastric cancer: a systematic review and meta-analysis.
BMC Cancer
; 19(1): 1125, 2019 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31747911
12.
Phase II study of adjuvant chemotherapy with S1 plus oxaliplatin for Chinese patients with gastric cancer.
BMC Cancer
; 18(1): 547, 2018 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29743043
13.
Safety and Efficacy of the S-1/Temozolomide Regimen in Patients with Metastatic Neuroendocrine Tumors.
Neuroendocrinology
; 106(4): 318-323, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-28817826
14.
Jinfu'an Decoction Inhibits Invasion and Metastasis in Human Lung Cancer Cells (H1650) via p120ctn-Mediated Induction and Kaiso.
Med Sci Monit
; 24: 2878-2886, 2018 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29735970
15.
The Significance and Therapeutic Potential of GATA3 Expression and Mutation in Breast Cancer: A Systematic Review.
Med Res Rev
; 35(6): 1300-15, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26313026
16.
Thyroid Metastases from Breast Cancer Case Report and Literature Review.
Curr Cancer Drug Targets
; 2024 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38409692
17.
Third-line Treatment for Metastatic Triple-negative Breast Cancer: A Systematic Review and Network Meta-analysis.
Am J Clin Oncol
; 47(2): 91-98, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38108387
18.
Validation of CTS5 Model in Large-scale Breast Cancer Population and Combination of CTS5 and Ki-67 Status to Develop a Novel Nomogram for Prognosis Prediction.
Am J Clin Oncol
; 47(5): 228-238, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38131531
19.
Incidence rate of osteonecrosis of jaw after cancer treated with bisphosphonates and denosumab: A systematic review and meta-analysis.
Spec Care Dentist
; 44(2): 530-541, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37219080
20.
Efficacy and safety of first-line treatment for metastatic triple-negative breast cancer: A network meta-analysis.
Cancer Pathog Ther
; 2(2): 81-90, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38601487